PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of tanLink to Publisher's site
 
Ther Adv Neurol Disord. 2008 July; 1(1): 3.
PMCID: PMC3002540

Editorial

figure 10.1177_1756285608091657-fig1

This is the first issue of Therapeutic Advances in Neurological Disorders. On behalf of the Associate Editors (Alberto Albanese, Marinos Dalakas and Matthew Walker) and our International Editorial Board, I would like to welcome you to the journal.

Our aim is to publish editorials, reviews and original research articles that advance clinical practice in this rapidly developing area of medicine. Essential elements of the journal include rapid peer review and publication so that latest opinion and evidence may be circulated to a wide audience. We encourage you to submit articles to us for this purpose. The Associate Editors and International Editorial Board bring together a wealth of experience and knowledge to this journal, which will help facilitate our high standard of publishing. We aim to complete peer review and reach a first decision on a paper within 3 weeks; accepted articles will be published online within 7 weeks. We will set high standards in peer review, with each research and review article being reviewed by at least two referees.

Topics and diseases covered include: neuroimmunology; movement and neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis – Lou Gehrig's disease, hemiballismus, tic disorder, and Gilles de la Tourette syndrome; pain; headache disorders such as migraine, cluster headache and tension headache; behavioral/ cognitive syndromes; sleep disorders; cerebral palsy; infections of the brain (encephalitis), brain meninges (meningitis), and spinal cord (myelitis); infections of the peripheral nervous system; neoplasms – tumors of the brain and its meninges (brain tumors), spinal cord tumors, tumors of the peripheral nerves (neuroma); demyelinating diseases of the central nervous system (such as multiple sclerosis), and of the peripheral nervous system (such as Guillain-Barré syndrome and chronic inflammatory demyelinating poly-neuropathy – CIDP); spinal cord disorders – tumors, infections, trauma, malformations (e.g. myelocele, meningomyelocele, tethered cord); disorders of peripheral nerves, muscle (myopathy) and neuromuscular junctions; traumatic injuries to the brain, spinal cord and peripheral nerves; altered mental status, encephalopathy, stupor and coma; speech and language disorders; epilepsy/seizure disorders.

Therapeutic Advances in Neurological Disorders is the fourth title in Sage's Therapeutic Advances series, following Cardiovascular and Respiratory disease titles launched last year, and a Gastroenterology journal last month. All the titles, including this one, will be freely available on Highwire for the first two volumes – until 2010 in our case. We aim to make the journal an attractive option for authors seeking a home for their articles.

We will be publishing bi-monthly from July 2008, with 3 issues this year and 6, annually, thereafter. Please join us in making this journal a timely and successful addition to the dissemination of information on improved treatment of neurological disorders.


Articles from Therapeutic Advances in Neurological Disorders are provided here courtesy of SAGE Publications